Log in or Sign up for Free to view tailored content for your specialty!
Oncology News
Geneoscopy RNA-FIT has high sensitivity for colorectal cancer
In this exclusive video, George Catinis, MD, medical director at the New Orleans Research Institute, discusses an RNA-FIT colorectal cancer screening test developed by Geneoscopy.
VIDEO: Healthy lifestyle key to pancreatic cancer prevention
In this exclusive video, Monique van Leerdam, MD, and Matthias Löhr, MD, PhD, discuss possible preventions for pancreatic cancer.
Log in or Sign up for Free to view tailored content for your specialty!
VIDEO: Early detection difficult in pancreatic cancer
In this exclusive video, Monique van Leerdam, MD, and Matthias Löhr, MD, PhD, discuss the need for better early detection of pancreatic cancer.
VIDEO: Pancreatic cancer should be considered a ‘medical emergency’
In this exclusive video, Monique van Leerdam, MD, and Matthias Löhr, MD, PhD, discuss the need for increased awareness about pancreatic cancer.
Cigarette smoking increases risk for CRC
The risk for colorectal cancer increased with cigarette smoking, according to a study published in the American Journal of Gastroenterology.
Optivista image-enhancing endoscopy superior for diagnosis of colorectal polyps
Optical diagnosis for colorectal polyps using Optivista image-enhancing endoscopy was superior to iScan image-enhancing endoscopy, according to results from Gastrointestinal Endoscopy.
FDA grants priority review to infigratinib for cholangiocarcinoma
The FDA granted priority review designation to infigratinib for the treatment of cholangiocarcinoma, according to the agent’s manufacturer.
Changes in duodenal fluid microbiome profile seen in pancreatic cancer
Patients with pancreas ductal adenocarcinoma, compared with pancreatic cysts or normal pancreata, had changes in their duodenal fluid microbiome profiles, according to study results.
Eight important updates for Pancreatic Cancer Awareness Month
November is Pancreatic Cancer Awareness Month.
FDA grants fast track status to SRF388 for hepatocellular carcinoma
The FDA granted fast track designation to SRF388 for treatment of certain patients with hepatocellular carcinoma, according to the agent’s manufacturer.
-
Headline News
First US case of clade I mpox reported in California
November 18, 20242 min read -
Headline News
'On the frontlines of public health': Physicians leverage trust against firearm violence
November 19, 20246 min read -
Headline News
Data support early, continued lecanemab dosing for Alzheimer’s
November 19, 20242 min read
-
Headline News
First US case of clade I mpox reported in California
November 18, 20242 min read -
Headline News
'On the frontlines of public health': Physicians leverage trust against firearm violence
November 19, 20246 min read -
Headline News
Data support early, continued lecanemab dosing for Alzheimer’s
November 19, 20242 min read